Genetic analysis of hereditary glomerulopathies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025372

Enrollment

150

Registered

2021-05-18

Start date

2021-05-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N07.9 N07.0 N07.1

Interventions

Group 1: After consenting by the treating physician, 1-3 ml of blood are obtained during clinical blood draw that is independent from the study. This is followed by high-throughput sequencing of genom

Eligibility

Sex/Gender

All

Age

0 Years to 100 Years

Inclusion criteria

Inclusion criteria: Suspected hereditary glomerulopathy.

Exclusion criteria

Exclusion criteria: Established genetic or non-genetic cause of the renal disease.

Design outcomes

Primary

Measure	Time frame
Molecular diagnosis of the observed clinical phenotype.	—

Secondary

Measure	Time frame
Exome analysis and analysis of all non-coding gene regions.	—

Countries

Germany

Contacts

Public ContactTobias Hermle

Medizinische Klinik IV, Nephrologie Universitätsklinikum Freiburg

tobias.hermle@uniklinik-freiburg.de01758214509

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026